What are the key components of a sequence listing?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.
According to MPEP 2412.01, a sequence listing must contain the following key components:
- A separate sequence for each sequence disclosed in the application
- Use of the symbols set forth in WIPO Standard ST.25 (1998)
- A unique identifier for each sequence (SEQ ID NO:)
- Separate presentation of nucleotides and amino acids
- Enumeration of nucleotides and amino acids
- A brief description of the sequences
- Other required identifying information
The MPEP states: “The sequence listing… must be a separate part of the disclosure and must include a summary of the invention… containing a list of sequence identifiers, accompanied by information concerning each sequence…“
Topics:
MPEP 2400 - Biotechnology
MPEP 2412.01 - Overview Of The Sequence Rules
Patent Law
Patent Procedure